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Abstract: Cutis laxa is a heterogeneous condition characterized by redundant, sagging, inelastic,
and wrinkled skin. The inherited forms of this disease are rare and can have autosomal dominant,
autosomal recessive, or X-linked inheritance. Three of the autosomal recessive cutis laxa syndromes,
namely cutis laxa IIA (ARCL2A), cutis laxa IIB (ARCL2B), and geroderma osteodysplastica (GO), have
very similar clinical features, complicating accurate diagnosis. Individuals with these conditions often
present with cutis laxa, progeroid features, and hyperextensible joints. These conditions also share
additional features, such as short stature, hypotonia, and congenital hip dislocation, but the severity
and frequency of these findings are variable in each of these cutis laxa syndromes. The characteristic
features for ARCL2A are abnormal isoelectric focusing and facial features, including downslanting
palpebral fissures and a long philtrum. Rather, the clinical phenotype of ARCL2B includes severe
wrinkling of the dorsum of the hands and feet, wormian bones, athetoid movements, lipodystrophy,
cataract and corneal clouding, a thin triangular face, and a pinched nose. Normal cognition and
osteopenia leading to pathological fractures, maxillary hypoplasia, and oblique furrowing from the
outer canthus to the lateral border of the supraorbital ridge are discriminative features for GO. Here
we present 10 Iranian patients who were initially diagnosed clinically using the respective features
of each cutis laxa syndrome. Each patient’s clinical diagnosis was then confirmed with molecular
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investigation of the responsible gene. Review of the clinical features from the cases reported from the
literature also supports our conclusions.
Keywords: autosomal recessive cutis laxa 2A; autosomal recessive cutis laxa 2B; geroderma
osteodysplastica; Pyrroline-5-carboxylate reductase 1 (PYCR1); ATPase, H+ transporting lysosomal
V0 subunit A2 (ATP6V0A2); GOLGIN, RAB6-INTERACTING (GORAB)
1. Introduction
Cutis laxa is a heterogeneous condition characterized by redundant, sagging, inelastic, and
wrinkled skin. The many forms of this disorder may have autosomal dominant, autosomal recessive,
or X-linked inheritance. The autosomal recessive cutis laxa conditions have been categorized into
types I, II, and III. Autosomal recessive cutis laxa type I ARCL1; Online Mendelian Inheritance in
Man (OMIM#219000) is characterized by systemic involvement with respiratory, cardiovascular, and
gastrointestinal manifestations. It is further divided into types IA (ARCL1A, OMIM#219100), IB
(ARCL1B, OMIM#614437), and IC (ARCL1C, OMIM# 613177) caused by mutations in the Fibulin 5
(FBLN5), EGF-CONTAINING FIBULIN-LIKE EXTRA CELLULAR MATRIX PROTEIN 2 (EFEMP2)
(formerly fibulin-4 FBLN4), and LATENT TRANFORMING GROWTH FACTO_BETA_BINDING
PROTEIN 4 (LTBP4) genes, respectively. Type II is divided into type IIA (ARCL2A,
OMIM#219200) and IIB (ARCL2B, OMIM#612940) caused by abnormal ATP6V0A2 and PYCR1 genes,
respectively [1–3] Type III is also divided into two types, type IIIA (ARCL3A, OMIM#219150)
and IIIB (ARCL3B, OMIM#614438), caused by mutations in ALDEHYDE DEHYDROGENASE 18
FAMILY, MEMBER A1 (ALDH18A1) and PYCR1 genes respectively. Geroderma osteodysplastica (GO,
OMIM#231070), another subtype of cutis laxa not included in this classification, is caused by recessive
mutations in the GORAB gene. Whereas macrocephaly, alopecia, cutis laxa, and scoliosis syndrome
(MACS, OMIM 613075) is caused by mutations in RIN2.
ARCL2A, ARCL2B, and GO manifest with many of the same features, making a definitive
clinical diagnosis difficult. ARCL2A is characterized by generalized cutis laxa, persistent open
fontanel, oxycephaly, and hyperextensible joints, with varying neurological, facial, and congenital
abnormalities. Neurological findings typically observed include developmental delay, intellectual
disability, hypotonia, microcephaly, hearing loss, seizures, and a cobble-like dysgenesis demonstrated
by MRI of the brain [4–6]. Eye abnormalities, such as myopia and strabismus, may also be present.
Facial dysmorphic features include frontal bossing, reverse V eyebrows, downslanting palpebral
fissures, a long philtrum, and sagging cheeks with anteverted nares. Additional features that may be
observed are intra-uterine growth retardation, blue sclera, pectus excavatum, inguinal hernia, flat feet,
and congenital hip dislocation [7,8]. Biochemical analysis revealed that these patients have a combined
defect of N- and O-glycosylation of serum proteins [1,4,9]. Affected individuals show a reduction in
the isoeclectric focusing main protein band, corresponding to transferrin containing four sialic acid
residues and increased amounts of disialo- and trisialo-transferrin that indicate altered N glycosylation
over the normal range [4,9,10]. Serum apolipoprotein C III isoelectric focusing also reveals reduction of
apolipoprotein CIII containing two sialic acid residues and increased amounts of monosialotransferrin.
Infants may have a normal transferrin isofocusing profile in the first months of their lives but, if
repeated later on, will develop the typical transferrin abnormality [9,10]. Biochemical analysis is good
for identification of ARCL2A patients but it cannot be used for identification of ARCL2B and GO cases.
ARCL2B is characterized by intra-uterine growth retardation, cutis laxa, wrinkling of skin,
particularly of dorsum of hands and feet, visible veins on the chest, congenital hip dislocation,
hyperextensible joints, and adducted thumbs. Phenotypic facial features include a broad and prominent
forehead, aged appearance, triangular face, and thin nose [11–14]. Neurological findings observed in
this condition are hypotonia, developmental delay, intellectual disability, and dysgenesis or agenesis
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of the corpus callosum [11]. Normal intelligence has been reported in a few patients [15–17]. Some
patients also demonstrate lipodystrophy, osteoporosis/osteopenia, and blue sclera. Biallelic PYCR1
mutations were identified in patients previously diagnosed with GO, wrinkly skin syndrome, or
ARCL2 [2,3], but these mutations are now classified as ARCL2B.
GO was first described by Bamatter et al. in five members from a Swiss family [18]. This condition
is characterized by premature aged appearance, drooping cheeks, maxillary hypoplasia, wrinkled skin,
and osteopenia [15]. There is also an oblique furrowing extending from the outer canthus to the lateral
border of the supraorbital ridge [19]. Due to the osteopenia, the bones, particularly the vertebrae, are
susceptible to fracture [20]. Individuals affected by GO do not have any intellectual disability, but
they may develop congenital hip dislocations, hypotonia and short stature. Hennies et al. identified
recessive mutations in the GORAB gene in patients diagnosed with GO [21].
Rajab et al. reported on 22 patients with the diagnosis of wrinkly skin syndrome or GO and
concluded that these are two distinct disorders. Genetic testing performed on many patients diagnosed
with wrinkly skin syndrome showed mutations in ATP6V0A2 or PYCR1 [1,2].
2. Patients
An in depth clinical evaluation, with documentation of phenotypic features, was completed
for each patient. Detailed clinical data was obtained by a standardized questionnaire. All families
provided written informed consent according to institutional guidelines. Ethics approval was obtained
by the Kariminejad-Najmabadi Pathology and Genetics Center ethical committee.
The observed characteristics and symptoms were then compared against the discriminative
features of each cutis laxa syndrome to preliminarily diagnose each patient. The clinical diagnoses
indicated which genes needed to investigated by Sanger sequencing in each case. In all cases the
candidate genes suggested by the clinical phenotype were then confirmed by molecular investigation.
Here we report 10 patients with ARCL2A, ARCL2B, or geroderma osteodysplastic (GO) and
discuss the clinical features that help differentiate between these three cutis laxa syndromes. The
clinical findings from each patient are reported in Table 1. Table 2 is a comparison of the frequency of
the clinical features observed in ARCL2A, ARCL2B, and GO as reported in the literature against the
frequency in our cases (Tables A1–A3).
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Table 1. Comparison of clinical features of cutis laxa IIA, IIB, and GO syndrome, and 10 patients with these cutis laxa conditions.
Diagnosis
Cutis
laxa IIA
Family I
Case 1
Family II
Case 2 * Cutis
laxa IIB
Family III
Case 3
FamilyIV
Case 4
Family IV
Case 5
Family V
Case 6 GO
Family VI
Case 7
Family VII
Case 8
Family VIII
Case 9
Family IX
Case 10
ARCL2A ARCL 2A ARCL2B ARCL2B ARCL2B ARCL2B GO GO GO GO
Age at examination 4 years 12 years 14 months 35 years 36 years 1 year 9 years 3 years 6 months 40 years
Sex F M F M M F F M F M
Intra-uterine growth
retardation + + + + + + + + - - - + NE
height 108 cm 95thcentile
140 cm 10th
centile
75 cm <50th
centile
173 cm <50th
centile
175 cm <50th
centile
68 cm <25th
centile
115 cm <3rd
centile
69 cm <3rd
centile
65 cm 50th
centile
158 cm <3rd
centile
weight 12 kg <3rdcentile
27 Kg <3rd
centile
6.8 kg <3rd
centile
40 kg <3rd
centile
45 <3rd
centile
6.2 kg <3rd
centile
24 kg <25th
centile
7.4 kg <3rd
centile
6.4 kg <50th
centile
50 kg <3rd
centile
Head Circumference 47.5 cm<50th centile
51 cm <50th
centile
42 cm <2nd
centile
53 cm <50th
centile
54.5 <50th
centile
40 cm <2nd
centile
50 cm <50th
centile
42 cm <2nd
centile
41 cm <25th
centile
57.5 cm
<98th centile
Facial features
Aged appearance + + +/− + + + + + + + + + +
Persistent open fontanel + NE + + - NE NE + − NE − − NE
Bossing forehead/broad
forehead + − − + + − − + − − + − −
Downslanting palpebral
fissures + + + − − − − − − − − − −
Reverse V eyebrows + + + − − − − − − − − − −
Long philtrum + + + − − − − − − − − − −
Anteverted nares + + + − − − − − − − − − −
Blue sclera + − − + + − − + − − − − −
Triangular face − − + + − + + − − − − −
Thin nose − − + + + + + − − − − −
Long face − − + ** − + + − − − − − −
prognathism − − + ** − + + − − − − − −
Maxillary hypoplasia − − − − − − − + + + − +
Oblique furrowing
extending from the outer
canthus to the lateral border
of the supraorbital ridge
− − − − − − − + − + + −
Drooping/sagging cheeks + + − − − − − − + + + +/− −
Neurological abnormalities
Developmental delay + + + + + + + + − − − − −
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Table 1. Cont.
Diagnosis
Cutis
laxa IIA
Family I
Case 1
Family II
Case 2 * Cutis
laxa IIB
Family III
Case 3
FamilyIV
Case 4
Family IV
Case 5
Family V
Case 6 GO
Family VI
Case 7
Family VII
Case 8
Family VIII
Case 9
Family IX
Case 10
ARCL2A ARCL 2A ARCL2B ARCL2B ARCL2B ARCL2B GO GO GO GO
Intellectual disability + + Very mild + + + + + − − − − −
Microcephaly − − + + − − + − − − − −
Hypotonia + + + at birth + + − − + − − − − −
Eye abnormalities −
Myopia + + − − NE − − − − − − − −
Strabismus + − + − + − − − − − − − −
Skeleton
Pectus excavatum + − + + − − − + − − − − −
Osteopenia + + − + + NE NE NE + + + + +
Fractures − − +/− − − − − + + − − +
Congenital hip dislocation + + − + − − − + +/− − − + −
Skin & joints
Hyperextensibility of joints + + + + + +/− +/− + + + + + −
Dislocations − − + - − + − − − − −
Adducted thumbs − − + + + + + − + − − −
Clenched hands − − + + − − + − + − − −
Increased palmar creases + + + + + + + + + +
Wrinkled skin + + + + + + + + + + + + +
Severe wrinkling of skin on
dorsum of hands and feet − − + + + + + − + − − −
Visible veins on the chest − − + + + + + − − + − −
Inguinal hernia + − + + − − − − − − + − −
Umbilical hernia − − + − − − + − − − + −
Lipodystrophy − − + − + + + − − − − −
Flat feet + − + + + + + + − − − +
Causative gene Mutation
cDNA Mutation protein ATP6V0A2
c.2255C>T
homozygous
mutation in
ATP6V0A2
novel
c.754delT
homozygous
mutation in
ATP6V0A2 22
c.797 G>A
homozygous
mutation in
PYCR1
gene 2,3
c. 355C>T
homozygous
mutation in
PYCR1
gene 2
c. 355C>T
homozygous
mutation in
PYCR1
gene 2
c.572G>A
homozygous
mutation in
PYCR1
gene 15
c.-1_1GA>CT
homozygous
mutation in
GORAB
gene 21
c.-1_1GA>CT
homozygous
mutation in
GORAB gene
c.391C>T
homozygous
mutation in
GORAB gene
novel
c.75_76delinsCT
homozygous
mutation in
GORAB
gene 21
other Glycosylationabnormalitites
Glycosylation
abnoramalities Cleft palate Small ASD
* Case 2 was previously reported by Gardeitchik et al., 2014 [22]; ** Case 6 was previously reported by Kretz et al., 2011 [15]; *** present in adulthood + present; − absent; F, Female;
M, Male; NE, Not evaluated.
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Table 2. Comparison of clinical features of cases with ARCL2A, ARCL2B, and GO in present cases and cases from the literature. NE, not evaluated.
Clinical Features
ARCL2A Total Cases from
Literature
ARCL2A
Present
Cases
ARCL2B Total Cases from the
Literature
ARCL2B
Present
Cases
GO Total Cases from the
Literature
GO
Present
Cases
Number of
Positive Cases
from Number of
Evaluated Cases
Frequency
(%)
Number of
Positive Cases
from Number of
Evaluated Cases
Frequency
(%)
Number of
Positive Cases
From Number of
Evaluated Cases
Frequency
(%)
Intra-Uterine Growth Retardation 7/17 41% 2/2 78/83 94% 4/4 0/9 0% 1/3
Postnatal Growth Delay 10/24 42% 0/2 43/64 67% 4/4 8/52 15% 3/4
Aged Appearance 25/25 100% 2/2 89/87 98% 4/4 49/53 92% 4/4
Persistent open Fontanel 53/58 91% 1/1 30/40 75% 1/2 2/12 17% 0/2
Blue sclera 2/4 50% 1/2 23/48 48% 2/2 1/19 5% 0/4
Intellectual Disability 45/58 78% 2/2 86/92 93% 4/4 3/53 6% 0/4
Microcephaly 33/47 70% 0/2 32/49 65% 2/4 1/53 2% 1/4
Hypotonia 29/35 83% 2/2 33/46 72% 2/4 13/38 34% 0/4
Seizures 13/53 25% 0/2 14/62 23% 0/4 1/49 2% 0/4
Athetoid/Dystonic Movements 1/15 6% 0/2 17/85 20% 0/4 0/49 0% 0/4
Corpus Callosum Dysgenesis 2/20 10% NE 26/53 49% NE 0/3 0% NE
Pachygryria 30/46 65% NE 0/53 0% NE 0/3 0% NE
Strabismus 21/48 44% 1/2 17/48 35% 1/4 0/3 0% 0/4
Cataract/corneal clouding 1/38 3% 0/2 13/88 15% 0/4 0/3 0% 0/4
Osteopenia NE NE 1/2 38/52 73% 1/1 50/52 96% 4/4
Fractures 5/55 9% 0/2 3/23 13% 0/4 39/53 74% 2/4
Congenital hip dislocation 9/15 60% 1/2 53/86 62% 1/4 36/53 68% 1/4
Wormian bonses NE NE 0/2 20/32 63% NE 15/36 42% NE
Hyperextensibility of joints 40/46 87% 2/2 75/79 95% 4/4 45/46 98% 3/4
Dislocations 0/7 0% 0/2 2/8 25% 2/4 NE NE 0/4
Adducted thumbs 0/5 0% 0/2 28/45 62% 4/4 NE NE 1/4
Wrinkled skin 60/60 100% 2/2 93/93 100% 4/4 53/53 100% 4/4
Visible veins on the chest NE NE 0/2 46/53 87% 4/4 9/43 21% 0/4
Hernia 17/36 47% 1/2 33/84 39% 2/4 1/43 2% 2/4
Flat feet 1/3 33% 1/2 5/7 71% 3/4 NE NE 1/4
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3. Discussion
Although there is a large phenotypic overlap among the three types of cutis laxa syndromes,
ARCL2A, ARCL2B, and GO, in this manuscript we highlight the main differences that allow for clinical
discrimination amongst them.
3.1. Overlapping Features
Cutis laxa, progeroid features, hyperextensible joints, inelastic wrinkled skin, and flat feet are
features found in all three cutis laxa syndromes (Figure 1a–o) (Table 2). All of our patients, regardless of
the cutis laxa syndrome, demonstrated flat feet however the frequency of feature has not been reported
in the literature. Hypotonia and congenital hip dislocation are also found in all three conditions, but the
severity and frequency of these findings varies. Short stature and open fontanel are common findings
in cutis laxa types 2A and 2B, but occur less frequently in GO (Table 2); however, in our patients 34
showed short stature. Osteopenia is characteristic of both ARCL2B and GO, though it is much more
severe in GO and may even lead to pathologic fractures, especially of the vertebral column. We cannot
comment on osteopenia in ARCL2A as it was not evaluated in the cases reported in the literature.
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and increased wrinkling in dorsum of feet in ARCL2B patient case 3; (m) hyperlaxity of joints in 
ARCL2B patient case 3; (n) flat feet in GO case 7; and (o) hyperlaxity of joints in GO in case 7. 
Figure 1. Overlapping clinical features of ARCL2A, ARCL2B, and GO cases. (a) Frontal view of patients
with cutis laxa IIA, case 1; (b) frontal view of pati nt with ARCL2B case 6, note pectus xcavatum,
translucent skin, and visible veins; (c) frontal view of patient with GO case 7, note aggi g and
overfolding of skin; (d,e) note wrinkling f skin in the dorsum of ands and increased palmar creases
in case 1; (f,g) adducted thumb seen in case 6; (h,i) wrinkling of skin and increased palmar creases
in case 7; (j) flat feet in ARCL2A case 1; (k) cutis laxa in ARCL2A in case 2; (l) flat feet and increased
wrinkling in dorsum of feet in ARCL2B patient case 3; (m) hyperlaxity of joints in ARCL2B patient
case 3; (n) flat feet in GO case 7; and (o) hyperlaxity of joints in GO in case 7.
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3.2. Facial Features
Each of the cutis laxa syndromes has distinct facial features. The ARCL2A patients demonstrate
frontal bossing, large open fontanels, reverse V eyebrows, downslanting palpebral fissures, strabismus,
a long philtrum and sagging cheeks with anteverted nares. The downslanting palpebral fissures and
long philtrum are particularly indicative of ARCL2A and may help in establishing the diagnosis. The
ARCL2B patients present during infancy and childhood with thin triangular faces, broad foreheads,
a thin nose, and thin skin. Patients with this syndrome usually lack the sagging cheeks commonly
seen in infants with ARCL2A and GO (Figure 2b). Though there are only a few adults with ARCL2B
reported in the literature, the evidence supports that in adulthood, this face is no longer triangular
but, rather, becomes long, with a prominent chin [15,17] (Figure 2c). Patient with GO demonstrate
maxillary hypoplasia, sagging cheeks, and oblique furrowing, which extends from the outer canthus to
the lateral border of the supraorbital ridge. This characteristic is generally more prominent in infancy
and childhood (Figure 2g,h).
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Figure 2. Comparison of aging in ARCL2A, ARCL2B, and GO. (a) Cutis laxa and facial dysmorphic
features improves considerably in cutis laxa IIA as seen in three sisters affected with this condition;
(b) the infant with ARCL2B has a triangular face (case 3); (c) The adult with ARCL2B has a long face
with prognathism (case 5); (d) the trunk in patient with ARCL2B, the skin is translucent showing
underlying vessels (case 3); (e) the trunk in the older patient shows i prove ent in translucency of
skin (case 4); (f) the hand is tightly clenched in infancy in ARCL2B patient case 3 but can be easily
opened as the child grows older; (g) infant with GO (case 9); (h) adult with GO (case 10); the GO patient
has the least dysmorphic features and there is no dramatic change in facial features.
3.3. Progeroid Features
Clinical findings vary as the children with these cutis laxa syndromes grow older. At birth, the
ARCL2B patients are usually very small with many having intrauterine growth retardation. The
adult ARCL2B patient, however, is not particularly short but usually has a low weight and exhibits
lipodystrophy (Figure 2c). ARCL2B infants have very thin skin, visible veins over thorax and clenched
hands, but these symptoms improve considerably as the patient grows older (Figure 2d–f). Infants
with GO usually have normal birth weights and lengths. The progeroid features improve in the
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majority of patients as the child grows older and reaches adult age. This progression is most obvious
in ARCL2A (Figure 2a) [5,7,17]. Contrary to the improvement in the progeroid features, the abnormal
fat distribution seen in ARCL2A worsens with age (Figure 3a–c) [4].
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Based on the patients examined in this study, it seems that joint hyperlaxity improves as the
patients reach adulthood. Hyperlaxity was seen in all of our child and infant cases, but of the three
adult cases reported in this manuscript (two ARCL2B patients and one GO patient), all had very mild
to absent joint hyperlaxity.
3.4. Neurological Features
The neurological findings common to ARCL2A and ARCL2B patient are intellec ual dis bility,
hypotonia, psychomot r retardation, microcephaly, and seizures. Patients wi h GO, however, only
demo strate hypotonia if they demonstrate any neurological findings at all. Brain MRI imaging would
be expe ted to differentiate between ARCL2A and ARCL2B based on the presenc of cobblestone
dysgenesis in ARCL2A compared to dysge esis or agenesis of corpus callosum in cutis laxa IIB
(Figure 4A–H) [2,5]. Brain MRI was not performed as part of this study and these features were not
evaluated in our report d . Additionally, thetoid movem nts can occasionally be seen in
ARCL2B and hearing loss ha been reported in ARCL2A.
Microcephaly may be congeni al or may develop during th c urse of dise se in ARCL2A [5].
Intellectual disability has been reported in ARCL2B but with the following exceptions: one large family
with a complete deletion of PYCR1 gene [16], in another patient with the c.138+1G>A mutation [2],
and in three patients with missense alterations not residing in exons 4 to 6 [17]. The frequency of
intellectual disability in ARCL2A is 78% based on all the reported cases in the literature. Almost all of
the patients with GO that have been reported in the literature have normal cognition (94%).
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Figure 4. (A,B,D) demonstrate frontal and frontotemporal cobblestone-like brain dysgenesis on lateral
T1 weighed images in three patients with cutis laxa IIA. Note the enlarged Virchow space under the
abnormally-developed brain region; (C,E,F) shows sagittal images of fronto-temporal cobblestone-like
brain dysgenesis on T2 and T1 weighted images in the same patients; (G) sagittal image showing
mild, frontal cobblestone-like brain dysgenesis; (I) control showing normal-sized corpus callosum; and
(H) agenesis of the corpus callosum in a cutis laxa IIB patient.
3.5. Discriminative Features in ARCL2A
The features unique to patients with ARCL2A are abnormal isoelectric focusing, downslanting
palpebral fissures, and a long philtrum.
3.6. Discriminative Features in ARCL2B
Facial features specific f r ARCL2B are a thin triangular face wit pinched nose in infancy and
childhood that progresses to a long face with a prominent chin in adulthood. Severe wri kling of
the d rsum of th hands nd feet is also more prominent in ARCL2B c mpared to ARCL2A and GO.
Though not seen in all pa ients with cutis laxa IIB, wormian bones, athetoid movements, lipodystrophy,
cataracts and corneal clouding are hig ly sp cific for ARCL2B. These features are either not seen or
very rarely seen in the other two cutis laxa syndromes [17].
3.7. Discriminative Features in GO
Patients wit GO have normal mentation, whereas the majority of the patients with ARCL2A and
ARCL2B have variable degrees of intellectual disability. While patients with ARCL2B may manifest
osteopenia, osteopenia that is severe enough to cause pathologic fractures is more characteristic of GO.
Facial features specific to GO are maxillary hypoplasia and oblique furrowing from the outer canthus
to the lateral border of the supraorbital ridge.
4. Conclusions
In conclusion, we believe that in spite of great similarity in ARCL2A, ARCL2B, and GO syndromes,
there are discriminative features unique to each condition that can guide accurate clinical diagnosis of
cutis laxa syndrome subtypes, so that we were able to correctly make the clinical diagnosis. Sanger
sequencing of the candidate gene would be much more cost effective to the general approach of
next-generation sequencing cutis laxa panels.
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Appendix A
Table A1. Clinical features in autosomal recessive cutis laxa 2A patients reported in the literature.
Clinical Features Morava et al.,2008 [4]
Van Maldergem
et al., 2008 [7]
Hucthagowder
et al., 2009 [6]
Fischer et al.,
2012 [23]
Greally et al.,
2014 [24]
Gardeitchik
et al. 2014 [22]
Bahena-Bahena
et al., 2014 [25]
Ritelli et al.,
2014 [26]
Goyal et al.,
2015 [27]
Cohen et al.,
2016 [28] Total
Diagnosis ARCL2A ARCL2A ARCL2A ARCL2A ARCL2A ARCL2A ARCL2A ARCL2A ARCL 2A ARCL2A
Intra-uterine growth retardation 2/10 NE NE NE 3/3 NE NE + + 0/2 5/7
Postnatal growth delay NE NE 7/17 NE 0/3 NE 2/2 - + NE 10/24
Aged appearance 10/10 11/11 NE NE NE NE 2/2 + + NE 4/4
Persistent open fontanel 10/10 11/11 16/17 10/12 3/3 NE 2/2 + NE 0/2 32/37
Blue sclera NE NE NE NE NE NE NE + + 0/2 2/4
Intellectual disability 8/10 11/11 12/17 6/11 3/3 NE 2/2 - + 2/2 27/37
Microcephaly 7/10 4/11 14/17 NE 3/3 NE 2/2 - + 2/2 23/26
Hypotonia 8/10 11/11 NE NE 1/3 6/6 2/2 - NE 12 10/13
seizures 3/10 5/11 1/17 NE 1/3 2/6 0/2 - - 1/2 5/30
Athetoid/dystonic movements NE NE NE NE 0/3 1/6 0/2 - - 0/2 1/15
Corpus callosum dysgenesis NE 1/11 NE NE 1/3 0/4 NE NE NE 0/2 1/9
Pachygryria/cobblestone
like dysgenesis 4/10 8/11 9/15 1/1 2/3 4/4 NE NE NE 2/2 18/25
Strabismus 7/10 0/11 13/17 NE NE 2/6 NE - - 1/2 16/27
Cataract/corneal clouding NE 0/11 0/17 NE NE 1/6 NE - - 0/2 0/27
Osteopenia NE NE NE NE NE NE NE NE - NE NE
Fractures NE 4/11 0/17 0/12 0/3 0/6 0/2 + - 0/2 1/44
Congenital hip dislocation NE 8/8 NE NE 0/3 NE NE - + 0/2 1/7
Wormian bonses NE NE NE NE NE NE NE NE NE NE NE
Hyperextensibility of joints 9/10 NE 14/17 10/12 3/3 NE 2/2 NE NE 2/2 31/36
Dislocations NE NE NE NE 0/3 NE NE - - 0/2 0/7
Adducted thumbs NE NE NE NE 0/3 NE NE NE NE 0/2 0/5
Wrinkled skin 10/10 11/11 17/17 13/13 3/3 NE 2/2 + + 2/2 39/39
Visible veins on the chest NE NE NE NE NE NE NE NE - NE NE
hernia NE 6/11 7/16 NE 2/3 NE 12 + - 0/2 11/25
Flat feet NE NE NE NE NE NE NE + NE 0/2 1/3
ARCL2A, autosomal recessive cutis laxa 2A; NE, not evaluated.
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Table A2. Clinical features in autosomal recessive cutis laxa 2B patients reported in the literature.
Clinical Features
Reversade
et al.,
2009 [2]
Guernsey
et al.,
2009 [3]
Yildirim
et al.,
2010 [16]
Lin et al.,
2011 [29]
Kretz
et al.,
2011 [15]
Dimopoulou
et al.,
2013 [17]
Nouri
et al.,
2013 [30]
Scherrer
et al.,
2013 [31]
Gardeitchik
et al. 2014
[22]
Rahmati
et al.,
2015 [32]
Goyal
et al.,
2015 [27]
Alazami
et al.,
2016 [33]
Vahidnezhed
et al.,
2016 [34] Total
Diagnosis ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B ARCL2B
Intra-uterine growth
retardation 29/31 5/5 4/4 2/2 6/6 23/25 - 1/1 NE + + + 5/5 69/83
Postnatal growth delay 4/13 5/5 0/4 1/2 6/6 21/28 NE 3/3 NE + + + NE 43/64
Aged appearance 31/31 5/5 4/4 2/2 6/6 29/30 + 3/3 NE + + + 5/5 86/87
Persistent open fontanel 3/6 3/3 2/3 1/2 NE 14/19 NE 3/3 NE - + + 2/2 31/40
Blue sclera NE 4/5 NE 1/2 1/6 13/30 NE NE NE + + - 2/2 23/47
Intellectual disability 34/35 5/5 4/4 2/2 3/6 27/29 + 3/3 NE NE + + 5/5 86/92
Microcephaly NE 4/5 2/4 2/2 4/5 19/27 NE 0/3 NE - + - NE 32/47
Hypotonia NE 0/3 NE 0/2 NE 25/30 NE 2/3 5/5 + - - NE 33/44
seizures NE NE 2/4 0/2 0/6 3/33 + 0/3 5/5 - - + 2/5 14/61
Athetoid /dystonic
movements 4/35 0/5 0/4
1
2 NE 9/28 NE 0/3 3/5 - - - NE 17/85
Corpus callosum
dysgenesis 15/21 2/3 1/4 0/2 NE 4/13 + NE 2/5 - NE + 0/2 26/53
pachygryria 0/21 0/3 0/4 0/2 NE 0/13 - NE 0/5 - NE - 0/2 0/53
Strabismus NE NE NE 12 1/6 12/27 NE 0/3 2/5 - - -
1
2 17/43
Cataract/corneal clouding 4/35 0/5 NE 0/2 0/6 4/27 NE 0/3 4/5 - - + 0/2 12/88
Osteopenia 12/18 0/1 4/4 0/2 3/3 14/16 NE 3/3 NE - - - 2/2 38/52
Fractures NE 0/3 0/4 0/2 1/6 NE NE 2/3 NE - - - 0/2 3/23
Congenital hip dislocation 19/34 2/4 14
1
2 4/6 15/25 NE 3/3 NE + + + 5/5 43/86
Wormian bonses 6/9 1/2 4/4 0/2 1/1 8/12 NE NE NE - NE - NE 20/32
Hyperextensibility of joints 35/35 NE 4/4 2/2 4/6 24/26 NE 3/3 NE NE NE + 2/2 75/79
Dislocations NE NE NE 0/2 NE NE NE 0/3 NE NE NE - 2/2 2/8
Adducted thumbs NE 3/3 4/4 12 4/6 13/26 NE 2/3 NE NE NE + NE 24/45
Wrinkled skin 35/35 3/3 4/4 2/2 6/6 31/31 + 3/3 NE + + + 5/5 93/93
Visible veins on the chest NE 5/5 4/4 2/2 6/6 24/31 NE NE NE + + + 2/2 46/53
hernia 17/35 2/3 1/4 0/2 0/6 10/28 NE 3/3 NE - - - NE 33/81
Flat feet NE NE NE NE 5/6 NE NE NE NE NE NE - NE 5/7
ARCL2B, autosomal recessive cutis laxa 2B; NE, not evaluated.
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Table A3. Clinical features in Geroderma Osteodysplastica patients reported in the literature.
Clinical Features Newman et al., 2008 [35] Al-Dosari et al., 2009 [19] Gardeitchik et al., 2014 [22] Alazami et al., 2016 [33] Total
Diagnosis GO GO GO GO GO
Intra-uterine growth retardation NE NE NE NE NE
Postnatal growth delay 5/9 1/7 NE 2/27 8/43
Aged appearance 10/10 7/7 NE 23/27 40/44
Persistent open fontanel NE 1/7 NE NE 1/7
Blue sclera 1/10 NE NE NE 1/10
Intellectual disability 0/10 0/7 NE 0/27 0/44
Microcephaly 0/10 0/7 NE 0/27 0/44
Hypotonia 8/8 NE 3/3 2/27 13/38
seizures 0/10 NE 1/3 0/27 1/40
Athetoid/dystonic movements 0/10 NE 0/3 0/27 0/40
Corpus callosum dysgenesis NE NE 0/3 NE 0/3
pachygryria NE NE 0/3 NE 0/3
Strabismus NE NE 0/3 NE 0/3
Cataract/corneal clouding NE NE 0/3 NE 0/3
Osteopenia 10/10 6/7 NE 26/27 42/44
Fractures 9/10 5/7 NE 17/27 31/44
Congenital hip dislocation 4/10 2/7 NE 25/27 31/44
Wormian bonses NE NE NE 15/27 15/27
Hyperextensibility of joints 10/10 NE NE 26/27 36/37
Dislocations NE NE NE NE NE
Adducted thumbs NE NE NE NE NE
Wrinkled skin 10/10 7/7 NE 27/27 44/44
Visible veins on the chest 0/10 NE NE 0/27 0/34
hernia 0/10 NE NE 0/27 0/34
Flat feet NE NE NE NE NE
NE, not evaluated.
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